LEASE AGREEMENTLease Agreement • September 1st, 2023 • Frequency Therapeutics, Inc. • Pharmaceutical preparations
THIS LEASE AGREEMENT (this “Lease”) is made as of this 10 day of August, 2020, between ARE-MA REGION NO. 59, LLC, a Delaware limited liability company (“Landlord”), and KORRO BIO, INC., a Delaware corporation (“Tenant”).
One Kendall Square Building 600/700 Suite 6-401 Cambridge, MA 02139Frequency Therapeutics, Inc. • September 1st, 2023 • Pharmaceutical preparations
On behalf of Korro Bio, Inc. (the “Company”), I am pleased to offer you the position of the Company’s Senior Vice President & General Counsel. The terms of your employment are set forth below in this Employment Agreement (the “Agreement”).
Re: Employment AgreementEmployment Agreement • September 1st, 2023 • Frequency Therapeutics, Inc. • Pharmaceutical preparations
On behalf of Korro Bio, Inc. (the “Company”), I am pleased to offer you the position of the Company’s Chief Executive Officer (“CEO”). The terms of your employment are set forth below in this Employment Agreement (the “Agreement”).
THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • September 1st, 2023 • Frequency Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of November 8, 2021, by and among Korro Bio, Inc., a Delaware corporation (the “Company”), and the Investors (as defined in Section 1 below).
